Bortezomib [Optimized for Cell Culture]

Hazard statements (CLP)

H361

Code

Statements

H361

Suspected of damaging fertility or the unborn child

SECTION 2: Hazards identification

GHS Classification GHS classification of chemical product Acute toxicity (Oral) Category 3 Acute toxicity (Inhalation) Category 3 Acute toxicity (Dermal) Category 3 Reproductive toxicity Category 2

Signal word

Danger

Hazard statements

Toxic if swallowed, in contact with skin or if inhaled. Suspected of damaging fertility or the unborn child.

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and under- stood. Avoid breathing dust. Wash skin thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Wear protective gloves/ protective clothing/ eye protection/ face pro- tection.

Response

IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor. IF exposed or concerned: Get medical advice/ attention. Take off immediately all contaminated clothing and wash it before reuse.

Storage

Store in a well-ventilated place. Keep container tightly closed. Store locked up.

Disposal

Dispose of contents/ container to an approved waste disposal plant.

Other hazards which do not result in classification

None known.

2.1 Classification of the substance or mixture

Acute toxicity (Oral) : Category 3 Acute toxicity (Inhalation) : Category 3 Acute toxicity (Dermal) : Category 3 Reproductive toxicity